Radiotherapy Alone Versus Concurrent or Adjuvant Chemoradiotherapy for Nasopharyngeal Carcinoma Patients with Negative Epstein–Barr Virus DNA after Induction Chemotherapy

Radiotherapy Alone Versus Concurrent or Adjuvant Chemoradiotherapy for Nasopharyngeal Carcinoma Patients with Negative Epstein–Barr Virus DNA after Induction Chemotherapy

The purpose of this study was to compare the efficacy and toxicity of induction chemotherapy (IC) plus radiotherapy (RT) and IC plus concurrent or adjuvant chemoradiotherapy (CCRT/AC) in nasopharyngeal carcinoma (NPC) patients with negative Epstein–Barr virus DNA (EBV DNA) after IC. A total of 547 N...

Full description

Bibliographic Details
Main Authors: Fangfang Kong, Guangsen Pan, Chengrun Du, Chaosu Hu, Hongmei Ying
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Cancers
Subjects:
nasopharyngeal carcinoma
EBV DNA
induction chemotherapy
concurrent chemotherapy
propensity score-matched analysis
Online Access:https://www.mdpi.com/2072-6694/15/6/1689

Similar Items

Similar Items